Facial Neuritis Clinical Trial
Official title:
Imaging of Facial Neuritis Using T2-weighted Gradient-echo Fast Imaging Employing Steady State Acquisition After Gadolinium Injection
| NCT number | NCT03543384 |
| Other study ID # | 6810 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | February 20, 2018 |
| Est. completion date | February 2019 |
Improved means of positive diagnosis of facial neuritis, the leading cause of peripheral facial palsy
| Status | Recruiting |
| Enrollment | 100 |
| Est. completion date | February 2019 |
| Est. primary completion date | February 2019 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Age 18-80 years - Subject giving their consent for their participation - Patients with neuritis facial (neuritis group) who benefited, between 2009 and 2016, from an MRI of the internal auditory ducts, with gadolinous product injection and on the MRI 3 Tesla - Patients with a perception deafness, without neuritis sign (control group) who also benefited from an MRI with gadolinous product injection on the MRI 3T with the same protocol. Exclusion Criteria: - Refusal to participate in the study |
| Country | Name | City | State |
|---|---|---|---|
| France | Service Imagerie 1 | Strasbourg |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Strasbourg, France |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Presence or absence of pathologic enhancement of the facial nerve on the symptomatological side of the T2 sequence (FIESTA-C) | 1 hour after the realization of the MRI |